Oliver Eickelberg, MD
Head of the Division
of Pulmonary Sciences and Critical Care Medicine
Oliver Eickelberg, MD, is the incoming Division Head for Pulmonary
Sciences and Critical Care Medicine at the University of Colorado. Dr.
Eickelberg received his MD from the Universities of Basel, Switzerland, and
Lubeck, Germany. He did post-doctoral training at Yale University and junior
faculty at the University of Giessen. He has been a member of the American
Thoracic Society (ATS) since 2001 and served on its Program Committee
(2005-2009) and the Planning Committee (current) of RCMB. Currently, Dr.
Eickelberg serves as an Associate Editor of the American Journal of Respiratory
and Critical Care Medicine (AJRCCM), PLoS One, and Scientific Reports.
Before coming to Colorado, Oliver was Chairman of the
Comprehensive Pneumology Center Munich, a joint initiative of the
Ludwig-Maximilians-University, the Asklepios Klinik Gauting, and the Helmholtz
Zentrum Munich. He also served as director of the Institute of Lung Biology and
Disease (iLBD) at the Helmholtz Zentrum Munich and Vice Chairman of the German
Center of Lung Research. Oliver Eickelberg’s research interests focus on the
mechanisms of lung injury and repair in idiopathic pulmonary fibrosis (IPF) and
chronic obstructive pulmonary disease (COPD). He investigates signaling
mechanisms that initiate and perpetuate the processes of myofibroblast
activation and epithelial-mesenchymal transition. Dr. Eickelberg has a
long-standing interest in the molecular mechanisms and therapeutic advances of
IPF and COPD, and has served on a number of committees and institutions for
this purpose. He is Co-Director of the Foundation (“Stiftung”) AtemWeg, a
non-profit foundation working for the cure of chronic lung disease and raising
public awareness about people suffering from these diseases.
Oliver Eickelberg has a keen interest in raising future
leaders in respiratory medicine. He is founding director of two graduate
programs solely dedicated to respiratory medicine in Germany, “Molecular
Biology and Medicine of the Lung (MBML)” and “Lung Biology and Disease (LBD)”
in Giessen and Munich, respectively.